Zevra Therapeutics Statistics
Total Valuation
ZVRA has a market cap or net worth of $532.58 million. The enterprise value is $531.79 million.
Important Dates
The next estimated earnings date is Tuesday, August 12, 2025, after market close.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ZVRA has 54.68 million shares outstanding. The number of shares has increased by 32.32% in one year.
| Current Share Class | 54.68M |
| Shares Outstanding | 54.68M |
| Shares Change (YoY) | +32.32% |
| Shares Change (QoQ) | +1.16% |
| Owned by Insiders (%) | 0.78% |
| Owned by Institutions (%) | 50.47% |
| Float | 46.01M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 9.15 |
| PS Ratio | 11.84 |
| Forward PS | 4.86 |
| PB Ratio | 12.98 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 13.10 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.02, with a Debt / Equity ratio of 1.51.
| Current Ratio | 3.02 |
| Quick Ratio | 2.79 |
| Debt / Equity | 1.51 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.37 |
Financial Efficiency
Return on equity (ROE) is -204.78% and return on invested capital (ROIC) is -45.85%.
| Return on Equity (ROE) | -204.78% |
| Return on Assets (ROA) | -27.73% |
| Return on Invested Capital (ROIC) | -45.85% |
| Return on Capital Employed (ROCE) | -49.32% |
| Revenue Per Employee | $687,932 |
| Profits Per Employee | -$1.56M |
| Employee Count | 59 |
| Asset Turnover | 0.25 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ZVRA has paid $16.62 million in taxes.
| Income Tax | 16.62M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +123.39% in the last 52 weeks. The beta is 1.96, so ZVRA's price volatility has been higher than the market average.
| Beta (5Y) | 1.96 |
| 52-Week Price Change | +123.39% |
| 50-Day Moving Average | 8.51 |
| 200-Day Moving Average | 8.19 |
| Relative Strength Index (RSI) | 65.75 |
| Average Volume (20 Days) | 683,778 |
Short Selling Information
The latest short interest is 4.71 million, so 8.62% of the outstanding shares have been sold short.
| Short Interest | 4.71M |
| Short Previous Month | 5.67M |
| Short % of Shares Out | 8.62% |
| Short % of Float | 10.24% |
| Short Ratio (days to cover) | 7.02 |
Income Statement
In the last 12 months, ZVRA had revenue of $40.59 million and -$91.99 million in losses. Loss per share was -$1.86.
| Revenue | 40.59M |
| Gross Profit | 32.00M |
| Operating Income | -71.88M |
| Pretax Income | -50.87M |
| Net Income | -91.99M |
| EBITDA | -65.40M |
| EBIT | -71.88M |
| Loss Per Share | -$1.86 |
Full Income StatementBalance Sheet
The company has $62.63 million in cash and $61.84 million in debt, giving a net cash position of $794,000 or $0.01 per share.
| Cash & Cash Equivalents | 62.63M |
| Total Debt | 61.84M |
| Net Cash | 794,000 |
| Net Cash Per Share | $0.01 |
| Equity (Book Value) | 41.02M |
| Book Value Per Share | 0.75 |
| Working Capital | 54.60M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$61.72 million and capital expenditures -$99,000, giving a free cash flow of -$61.82 million.
| Operating Cash Flow | -61.72M |
| Capital Expenditures | -99,000 |
| Free Cash Flow | -61.82M |
| FCF Per Share | -$1.13 |
Full Cash Flow StatementMargins
Gross margin is 78.84%, with operating and profit margins of -177.09% and -226.64%.
| Gross Margin | 78.84% |
| Operating Margin | -177.09% |
| Pretax Margin | -185.68% |
| Profit Margin | -226.64% |
| EBITDA Margin | -161.14% |
| EBIT Margin | -177.09% |
| FCF Margin | n/a |
Dividends & Yields
ZVRA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -32.32% |
| Shareholder Yield | -32.32% |
| Earnings Yield | -17.27% |
| FCF Yield | -11.61% |
Analyst Forecast
The average price target for ZVRA is $22.75, which is 133.57% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $22.75 |
| Price Target Difference | 133.57% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 74.16% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 28, 2020. It was a reverse split with a ratio of 0.0625:1.
| Last Split Date | Dec 28, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.0625:1 |
Scores
ZVRA has an Altman Z-Score of -3.28 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.28 |
| Piotroski F-Score | 3 |
